Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Aryl Hydrocarbon Receptor
    (29)
  • AhR
    (19)
  • Endogenous Metabolite
    (4)
  • p53
    (3)
  • Antifungal
    (2)
  • Autophagy
    (2)
  • Decarboxylase
    (2)
  • Ferroptosis
    (2)
  • Androgen Receptor
    (1)
  • Others
    (17)
Filter
Search Result
Results for "

hydrocarbon,ahr

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    64
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • PROTAC Products
    1
    TargetMol | PROTAC
  • Natural Products
    14
    TargetMol | Natural_Products
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
  • Isotope Products
    1
    TargetMol | Isotope_Products
CH-223191
CH 223191
T2448301326-22-7
CH-223191 is a potent and specific antagonist for the aryl hydrocarbon receptor (AhR).
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
PD98059
PD 98059
T2623167869-21-8
PD98059 is an MEK inhibitor that inhibits MEK1 and MEK2 (IC50=2 50 μM) and is non-ATP-competitive. PD98059 is also antagonistic as a ligand for AHR. PD98059 inhibits autophagy.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Pifithrin-α hydrobromide
Pifithrin-α (PFTα) HBr, Pifithrin-α, Pifithrin hydrobromide, PFTα hydrobromide, PFTα
T270763208-82-2
Pifithrin-α hydrobromide (Pifithrin-α hydrobromide) is a p53 inhibitor, inhibiting p53-dependent transactivation of p53-responsive genes.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
BAY-218
AHR antagonist 1
T56222162982-11-6
Bindarit (AF2838)is an aryl hydrocarbon receptor (AHR) antagonist with IC50 of 39.9 nM in the human glioblastoma U87 cell line. BAY-218 inhibition of AhR stimulates pro-inflammatory monocyte and T cell responses in vitro and drives anti-tumor immune responses, leading to reduced tumor growth in vivo.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
AHR antagonist 2
T102692338747-54-7In house
AHR antagonist 2 is an antagonist of the aryl hydrocarbon receptor. The IC50s for human AHR and mouse AHR are 0.885 and 2.03 nM, respectively.
  • Inquiry Price
6-8 weeks
Size
QTY
ANI-7
T10325931417-26-4In house
ANI-7 is an activator of the aryl hydrocarbon receptor (AhR) pathway, inhibiting the growth of various cancer cells and selectively inhibiting the growth of MCF-7 breast cancer cells (GI50: 0.56 μM).
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Sale
β-NF-JQ1
T105262380000-55-3In house
β-NF-JQ1 is a PROTAC that recruits aryl hydrocarbon receptor E3 (AhR E3) ligase to target proteins. Using β-NF as an AhR ligand, it targets bromodomain (BRD)-containing proteins and induces AhR and BRD protein interactions. β-NF-JQ1 exhibits potent anticancer activity associated with protein knockdown activity.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Sale
DiMNF
3',4'-Dimethoxy-αNF
T2272514756-24-2In house
DiMNF (3',4'-Dimethoxy-αNF) is a selective and potent modulator of the aryl hydrocarbon receptor (AHR) and an AHR ligand with anti-inflammatory activity that inhibits cytokine-mediated induction of complement factor genes.
  • Inquiry Price
7-10 days
Size
QTY
AHR antagonist 5 free base
T397622247950-42-9In house
AHR antagonist 5 free base is an orally active AHR antagonist with IC50 of approximately 35-150 nM in human and rodent cell lines, and exhibits anticancer activity.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
KYN-101
KYN101, KYN 101
T720562247950-73-6In house
KYN-101 is an orally active and selective aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity. KYN-101 decreases CYP1A1 mRNA expression and can be used in the study of breast cancer and acute myeloid leukemia. KYN-101 is an orally active and selective aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity.
  • Inquiry Price
Size
QTY
AHR Inhibitor I-103
T853432247951-12-6In house
AHR Inhibitor I-103 is an aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity used in the study of breast cancer and acute myeloid leukemia.
  • Inquiry Price
Size
QTY
Benzyl butyl phthalate
BBP, 1,2-benzenedicarboxylic acid, butyl phenylmethyl ester, Butyl benzyl phthalate
T064085-68-7
Benzyl butyl phthalate (1,2-benzenedicarboxylic acid) is used as a plasticizer for PVC.
  • Inquiry Price
Size
QTY
Diosmin
Venosmine, Diosmil, Barosmin
T0878520-27-4
Diosmin (Venosmine) is a bioflavonoid that strengthens vascular walls.
  • Inquiry Price
Size
QTY
Carbidopa monohydrate
S(-)-Carbidopa, Carbidopa Hydrate
T214838821-49-7
Carbidopa monohydrate (S(-)-Carbidopa) is an inhibitor of DOPA decarboxylase, preventing the conversion of levodopa to dopamine.
  • Inquiry Price
Size
QTY
Indole-3-carbinol
Indole-3-Methanol, I3C, 3-Indolemethanol
T2947700-06-1
Indole-3-carbinol (I3C), a naturally occurring, orally available cleavage product of the glucosinolate glucobrassicanin, inhibits NF-κB and IκBα kinase activation.
  • Inquiry Price
Size
QTY
Carbidopa
Lodosyn, (S)-(-)-Carbidopa
T679528860-95-9
Carbidopa (Lodosyn) is an aromatic-L-amino-acid decarboxylase inhibitor (IC50: 29±2 μM). It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA.
  • Inquiry Price
Size
QTY
AHR antagonist 4
T102712242465-58-1In house
AHR antagonist 4 is a potent aryl hydrocarbon receptor (AHR) antagonist(example 293; IC50: 82.2 nM).It has anti-cancer effects.
  • Inquiry Price
8-10 weeks
Size
QTY
StemRegenin 1
SR1
T18311227633-49-9
StemRegenin 1 (SR1) is an aryl hydrocarbon receptor (AhR) inhibitor.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
YL-109
T196036341-25-0
YL-109, a novel anticancer agent, can inhibit breast Y cell growth and invasiveness in vitro and in vivo.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Pifithrin-β hydrobromide
Cyclic Pifithrin-α hydrobromide, Cyclic PFT-α, Pifithrin-β, PFT-β, PFT β (hydrobromide)
T3637511296-88-1
Pifithrin-β hydrobromide (Cyclic PFT-α) is an inhibitor of p53; reversibly blocks p53-dependent transcriptional activation and apoptosis. Protects against neuronal death in models of stroke and neurodegenerative disorders. Active in vivo; protects mice from the side-effects of Y therapy associated with p53 induction. Supresses self-renewal of embryonic stem cells. Also aryl hydrocarbon receptor (AHR) agonist, causes upregulation of AHR target gene CYP1A1 (EC50 = 1.1 μM).
  • Inquiry Price
Size
QTY
Tapinarof
WBI 1001, GSK2894512, Benvitimod
T464479338-84-4
Tapinarof (Benvitimod) is targeted as a topical cream treatment for psoriasis, a chronic autoimmune skin disease.
  • Inquiry Price
Size
QTY
GNF351
T154101227634-69-6
GNF351 is a full antagonist of the aryl hydrocarbon receptor (AHR)with the capacity to inhibit both DRE-dependent and -independent activity. GNF351 is minimal toxicity in mouse or human keratinocytes. GNF351 competes with a photoaffinity AHR ligand for binding to the AHR (IC50: 62 nM).
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
5-fluoro 203
NSC-703786, 5F-203
T21704260443-89-8
5-fluoro 203 (NSC-703786) is a cytotoxic molecule leading to cell death by forming DNA adducts. 5-fluoro 203 induces aryl hydrocarbon receptor signaling, and elevates expression of CYP1A1. 5-fluoro 203 treatment of cells also leads to elevation of reactive oxygen species and activation of p38, JNK and ERK.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
1,4-Chrysenequinone
Chrysene-1,4-dione
T10007100900-16-1
1,4-Chrysenequinone (Chrysene-1,4-dione) is an activator of aryl hydrocarbon receptor (AhR).
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale